Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07553858 · ClinicalTrials.gov registry record · NA
Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Not yet
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT07553858 is a NA study that has not yet begun recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 34 participants.
The verdict
NCT07553858, a NA study, has not yet begun recruiting, sponsored by Rutgers, The State University of New Jersey.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if endoscopic ultrasound guided (EUS guided) spontaneous porto-systemic shunt (SPSS) embolization works to treat refractory hepatic encephalopathy in adults. It will also learn about the safety of EUS guided embolization. The main questions it aims to answer are: 1. Does EUS guided embolization maintain an acceptable safety profile? 2. Does EUS guided embolization of large SPSS result in significant clinical improvement in patients with refractory hepatic encephalopathy? Participants will: 1. Receive EUS guided embolization or medical management. 2. Receive follow-up EUS procedures one month after embolization for assessment of the shunt patency and development of varices (embolization group). 3. Receive follow-up every week for 4 weeks to assess degree of worst episode of hepatic encephalopathy via West Haven criteria.
Interventions
- PROCEDURE Endoscopic ultrasound-guided transgastric embolization of the spontaneous portosystemic shunts
- PROCEDURE Interventional Radiology for shunt embolization/retrograde tranvenous obliteration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07553858
The ClinicalTrials.gov registry entry for NCT07553858 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endoscopic ultrasound-guided transgastric embolization of the spontaneous portosystemic shunts is the first listed.
NCT07553858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07553858 about?
NCT07553858 is a clinical study titled "Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy". The goal of this clinical trial is to learn if endoscopic ultrasound guided (EUS guided) spontaneous porto-systemic shunt (SPSS) embolization works to treat refractory hepatic encephalopathy in adults. It will also learn about the safety of EUS guided embolization. The main questions it aims to answ...
What is the current status of trial NCT07553858?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2026-05-01. Estimated completion is 2028-11-01.
What interventions are being tested in trial NCT07553858?
The interventions under investigation include: Endoscopic ultrasound-guided transgastric embolization of the spontaneous portosystemic shunts (PROCEDURE), Interventional Radiology for shunt embolization/retrograde tranvenous obliteration (PROCEDURE).
Who is sponsoring clinical trial NCT07553858?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.